pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,417 catalysts · 5,159 phase readout · 2,286 8k filing · 315 pdufa · 257 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 14 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: earnings×type: adcom×type: phase readout×clear all
type
  • phase readout5,159
  • 8k filing2,286
  • pdufa315
  • earnings257
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›WITHDRAWNphase readoutNCT07219381: Holistic Medicine Treatment of Uterine Fibroids-Adults

Sponsor: Virtual Tribunal Monastery. Phase: NA. Conditions: Uterine Fibroids - 1St Diagnosis, Uterine Fibroids Affecting Pregnancy, Uterine Fibroid Degenerated

full page →ctgov ↗
›COMPLETEDphase readoutNCT04498481: TREATMENT AND MONITORING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS RECEIVING PALBOCICLIB COMBINATION TREATMENT (WITH AI OR FULVESTRANT) FOR HR+/HER2- A/MBC IN A COMMUNITY ONCOLOGY SETTING.

Sponsor: Pfizer. Phase: . Conditions: Breast Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07527481: Nortriptyline and the Risk of Serious Adverse Events

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's. Phase: . Conditions: Chronic Kidney Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT05934019: Efficacy of a Transdiagnostic Online Prevention Approach in Adolescents (EMPATIA)

Sponsor: University of Bern. Phase: NA. Conditions: Mental Health Issue, Transdiagnostic Mechanisms, Adolescent Psychology, Prevention, Online Intervention, Psychological Intervention, Mental Disorder in Adolescence, Subclinical

full page →ctgov ↗
›COMPLETEDphase readoutNCT07456319: Sustainable Insect-based Protein Supplement in the Elderly: a Pilot Study

Sponsor: Universitat Oberta de Catalunya. Phase: NA. Conditions: Aging, Nutrition, Sustainable Diets, Cardiometabolic Health

full page →ctgov ↗
›RECRUITINGphase readoutNCT05363319: An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) in Routine Clinical Practice Settings in Europe

Sponsor: Regeneron Pharmaceuticals. Phase: . Conditions: Non-small Cell Lung Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07380230: Efficacy and Safety of Qibei Jiedu Formula for Preventing and Managing Acute Radiation Dermatitis in Breast Cancer Patients

Sponsor: LI FENG. Phase: NA. Conditions: Acute Radiation Dermatitis, Traditional Chinese Medicine (TCM), Breast Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07321730: Surgeons' Ability to Predict Pathological and Molecular Features of Peritoneal Carcinomatosis in Ovarian Cancer

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: . Conditions: Ovarian Cancer

full page →ctgov ↗
›SUSPENDEDphase readoutNCT06806228: Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status)

Sponsor: Petrov, Andrey. Phase: PHASE1. Conditions: Glioblastoma Multiforme, Diffuse Midline Glioma, H3 K27M-Mutant, Gliosarcoma, Giant Cell Glioblastoma, GBM

full page →ctgov ↗
›COMPLETEDphase readoutNCT04699630: A Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer

Sponsor: SCRI Development Innovations, LLC. Phase: PHASE2. Conditions: Metastatic Breast Cancer, Locally Advanced Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07493928: HPV After chemoRadioTherapy

Sponsor: General University Hospital, Prague. Phase: . Conditions: Cervical Cancer Recurrent, Radiotherapy, Cell Free DNA, HPV

full page →ctgov ↗
›COMPLETEDphase readoutNCT00898365: Study of Kidney Tumors in Younger Patients

Sponsor: Children's Oncology Group. Phase: . Conditions: Adult Cystic Nephroma, Anaplastic Kidney Wilms Tumor, Angiolipoma, Cellular Congenital Mesoblastic Nephroma, Classic Congenital Mesoblastic Nephroma, Clear Cell Sarcoma of the Kidney, Congenital Mesoblastic Nephroma, Cystic Partially Differentiated Kidney Nephroblastoma, Diffuse Hyperplastic Perilobar Nephroblastomatosis, Extrarenal Rhabdoid Tumor, Kidney Medullary Carcinoma, Kidney Neoplasm, Kidney Oncocytoma, Kidney Wilms Tumor, Metanephric Adenofibroma, Metanephric Adenoma, Metanephric Stromal Tumor, Metanephric Tumor, Mixed Congenital Mesoblastic Nephroma, Ossifying Renal Tumor of Infancy, Papillary Renal Cell Carcinoma, Renal Cell Carcinoma, Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions, Rhabdoid Tumor of the Kidney, Wilms Tumor

full page →ctgov ↗
›COMPLETEDphase readoutNCT00156767: Adrenal Function in Critical Illness

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: . Conditions: Adrenal Insufficiency

full page →ctgov ↗
›RECRUITINGphase readoutNCT07393867: Androgen-responsive POSLUMA-guided Intra-prostatic Boost

Sponsor: Martin T. King, MD, PhD. Phase: PHASE2. Conditions: Intermediate Risk Prostate Cancer, High Risk Prostate Cancer, Prostate Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07499765: Benefits of Formalized Care Support Program Following Acute Leukemia Diagnosis

Sponsor: Centre Henri Becquerel. Phase: NA. Conditions: Acute Leukemia

full page →ctgov ↗
›COMPLETEDphase readoutNCT03635567: Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)

Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE3. Conditions: Cervical Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05464667: Preoperative Irradiation for Stage I Breast Cancer

Sponsor: Parul Barry. Phase: NA. Conditions: Breast Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07646600: Observational Study of Natural History of BAG3 Gene Mutation-Associated Dilated Cardiomyopathy in Chinese Adults

Sponsor: AstraZeneca. Phase: . Conditions: Dilated Cardiomyopathy

full page →ctgov ↗
›RECRUITINGphase readoutNCT01587300: Neuroblastoma Biology Study

Sponsor: New Approaches to Neuroblastoma Therapy Consortium. Phase: . Conditions: Neuroblastoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06004882: Peripheral Nerve Stimulation of Genicular Nerves Versus Conventional Therapy With Intra-articular Steroid Injection for Chronic Knee Pain: A Prospective, Randomized Pilot Study

Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Peripheral Nerve Stimulation, Genicular Nerves, Chronic Knee Pain

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07543224: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of RSS0393 Ointment in Adult Patients With Plaque Psoriasis.

Sponsor: Reistone Biopharma Company Limited. Phase: PHASE3. Conditions: Plaque Psoriasis Subjects

full page →ctgov ↗
›RECRUITINGphase readoutNCT01386424: Screening for LID Clinical Studies Unit Healthy Volunteer Protocols

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Zika, Influenza

full page →ctgov ↗
›COMPLETEDphase readoutNCT01296724: PREMAPIV : Intravesical Pressure Variation at Different Bladder Instillation Volumes in Newborn Children

Sponsor: Rennes University Hospital. Phase: NA. Conditions: Intensive Care Unit Syndrome

full page →ctgov ↗
›TERMINATEDphase readoutNCT04363580: Creation of Auditory Processing Disorder Screening Tool in French

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Auditory Processing Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT04232280: Dose-Finding Trial to Evaluate the Safety and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647 in Healthy Adults

Sponsor: ModernaTX, Inc.. Phase: PHASE2. Conditions: Cytomegalovirus Infection

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07227896: Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson Disease

Sponsor: AbbVie. Phase: . Conditions: Parkinson's Disease

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07672496: Ulinastatin on Systemic Immune-Inflammation in Patients With Complicated Intra-Abdominal Infection

Sponsor: Fujian Medical University Union Hospital. Phase: NA. Conditions: Complicated Intra-abdominal Infection (cIAI), Systemic Inflammatory Response, Sepsis, Immune Dysfunction

full page →ctgov ↗
›COMPLETEDphase readoutNCT07007546: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABSK061 Mini-tablets in Healthy Adult Participants

Sponsor: Abbisko Therapeutics Co, Ltd. Phase: PHASE1. Conditions: Healthy

full page →ctgov ↗
›RECRUITINGphase readoutNCT06997588: EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)

Sponsor: Novartis Pharmaceuticals. Phase: PHASE2. Conditions: PIK3CA-related Overgrowth Spectrum (PROS)

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07197788: Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study

Sponsor: Endogenex, Inc.. Phase: NA. Conditions: Type 2 Diabetes Mellitus, Type2diabetes, Diabetes Mellitus, Type 2, Type 2 Diabetes, Diabetes

full page →ctgov ↗
›RECRUITINGphase readoutNCT07496203: The Effectiveness of BETY in Knee Osteoarthritis With Intra-Articular Injections

Sponsor: Hacettepe University. Phase: NA. Conditions: Osteo Arthritis of the Knee, Pain, Pain Management, Exercise

full page →ctgov ↗
›COMPLETEDphase readoutNCT07598942: Gingival TrxR1 Expression in Periodontal Health and Periodontitis

Sponsor: Ataturk University. Phase: . Conditions: Periodontitis, Oxidative Stress

full page →ctgov ↗
›RECRUITINGphase readoutNCT04631042: Developing Brain, Impulsivity and Compulsivity

Sponsor: National Institute of Mental Health (NIMH). Phase: . Conditions: Typical Development, Obsessive Compulsive Disorder, Conduct Disorder, Attention Deficit Hyperactivity Disorder, Autism Spectrum Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT06284642: Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)

Sponsor: Second Affiliated Hospital of Nanchang University. Phase: PHASE4. Conditions: Aneurysmal Subarachnoid Hemorrhage

full page →ctgov ↗
›RECRUITINGphase readoutNCT05711186: Structured Shared Decision Making for Patients Undergoing SAVR or TAVR

Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: NA. Conditions: Aortic Valve Stenosis, Symptomatic Aortic Stenosis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07104383: VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

Sponsor: Viking Therapeutics, Inc.. Phase: PHASE3. Conditions: Weight Loss

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06486441: Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)

Sponsor: Gilead Sciences. Phase: PHASE3. Conditions: Endometrial Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06156254: Community Care Intervention to Decrease COVID-19 Vaccination Inequities

Sponsor: RAND. Phase: NA. Conditions: COVID-19 Vaccination

full page →ctgov ↗
›RECRUITINGphase readoutNCT06658405: Clinical Trial Evaluating Secondary HPV Vaccination After Treatment of High-grade Cervical Lesions

Sponsor: Centre Oscar Lambret. Phase: PHASE2. Conditions: Cervical Lesion

full page →ctgov ↗
›COMPLETEDphase readoutNCT07597694: Verbal Intent and Gaze Cues on Action Prediction in ASD

Sponsor: University of Electronic Science and Technology of China. Phase: . Conditions: Autism Spectrum Disorder (ASD), Intellectual Disability

full page →ctgov ↗
›RECRUITINGphase readoutNCT06747156: A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Refractory Autoimmune Diseases

Sponsor: Ruijin Hospital. Phase: EARLY_PHASE1. Conditions: Autoimmune Diseases

full page →ctgov ↗
›RECRUITINGphase readoutNCT06739122: A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Type 2 Diabetes

full page →ctgov ↗
›COMPLETEDphase readoutNCT04545151: Verapamil SR in Adults With Type 1 Diabetes

Sponsor: Medical University of Graz. Phase: PHASE2. Conditions: Diabetes Mellitus, Type 1

full page →ctgov ↗
›COMPLETEDphase readoutNCT02192151: Study of PHN131 in Healthy Volunteers

Sponsor: PhytoHealth Corporation. Phase: . Conditions: Analgesia Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT06464029: Pathways Mediating Impaired Postural Control in Parkinson's Disease

Sponsor: University of Minnesota. Phase: . Conditions: Parkinson Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT07601529: Comparison of Anterior Sciatic Nerve Block and Adductor Magnus Muscle Plane Block for Anterior Cruciate Ligament Surgery

Sponsor: Ataturk University. Phase: NA. Conditions: ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION

full page →ctgov ↗
›RECRUITINGphase readoutNCT06743529: Immediate Versus Substantiated Antibiotic Therapy in Suspected Non-Severe Ventilator-Associated Pneumonia

Sponsor: Nantes University Hospital. Phase: NA. Conditions: Ventilator-Associated Pneumonia (VAP)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06737731: A Phase I/II Clinical Study of SHR-1681 for Injection in Patients With Advanced Solid Tumors

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.. Phase: PHASE1. Conditions: Malignant Solid Tumors

full page →ctgov ↗
›RECRUITINGphase readoutNCT07451431: Efficacy and Safety of Mirogabalin in Diabetic Peripheral Neuropathic Pain

Sponsor: Bangladesh Medical University. Phase: PHASE4. Conditions: Diabetic Peripheral Neuropathic Pain (DPNP)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06033131: PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia

Sponsor: Lina Bergman. Phase: PHASE3. Conditions: Preeclampsia

full page →ctgov ↗
← prev
page 82 of 109
next →